Morgan Stanley Knock-Out VEEV/ DE000ME3PH94 /
13/11/2024 08:53:40 | Chg.-0.11 | Bid12:55:37 | Ask12:55:37 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
7.75EUR | -1.40% | 7.72 Bid Size: 400 |
7.83 Ask Size: 400 |
Veeva Systems Inc | 153.278 USD | 31/12/2078 | Call |
GlobeNewswire
01/07
TRACON Pharmaceuticals Announces Termination of ENVASARC Trial and Will Explore Strategic Alternativ...
GlobeNewswire
15/05
Artificial Intelligence Enabled Technologies Transforming Healthcare Industry Creating Multi-Billion...
GlobeNewswire
09/01
Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clini...
GlobeNewswire
12/10/2023
Dr. Yooni Kim, Vice President of Clinical Services at Novotech, Delivers Keynote Address at Veeva Ko...
GlobeNewswire
16/09/2021
Litify Continues to Grow at Rapid Scale - Adds High-Profile Customer Experience Leader Hogan Hagy to...
GlobeNewswire
03/08/2021
Explorium Expands Go-to-Market Leadership to Accelerate Adoption of its External Data Platform
GlobeNewswire
07/06/2021
Impel NeuroPharma Announces First Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
23/03/2021
Aktana Delivers Intelligent Engagement Solution to Emerging and Mid-sized Life Sciences Companies
GlobeNewswire
25/02/2021
HealthTech Trends 2021: CEO’s of Teladoc, Reliq Health, Relay Medical and Veeva Systems, Driving Rev...
GlobeNewswire
20/01/2021
Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors
GlobeNewswire
12/01/2021
Leading $2.8 Trillion US Healthcare Market: CEO’s of 1life Healthcare, Skylight Health, Veeva System...
GlobeNewswire
05/11/2020
Axsome Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
GlobeNewswire
04/11/2020
Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ ...
GlobeNewswire
07/10/2020
Capital Market Laboratories (CMLviz) One on One with Veeva Systems (VEEV) CFO - Move to digital was ...